Baskin Esra, Bakkaloglu Aysin, Besbas Nesrin, Hascelik Gulsen, Saatci Umit, Gök Faysal, Ozen Seza
Department of Pediatric Nephrology, Hacettepe University, Ankara, Turkey.
Pediatr Nephrol. 2002 Nov;17(11):917-9. doi: 10.1007/s00467-002-0969-0. Epub 2002 Oct 16.
Anti-myeloperoxidase (MPO) antibodies are associated with the development of anti-neutrophil cytoplasmic antibody (ANCA)-related vasculitis. The imbalance between the protease-antiprotease activity in the neutrophils has been implicated in the pathogenesis of ANCA-related vasculitis. Ceruloplasmin is an acute-phase protein that has antiproteinase and antioxidant properties and inhibits MPO activity. We attempted to study the association between serum ceruloplasmin and ANCA in childhood vasculitis. Forty-five ANCA-related diseases were included in the study. The age range was 4-16 years. Patients were divided into two groups based on indirect immunofluorescence and/or ELISA specificity (MPO). Twenty-six patients had p-ANCA- and 19 patients had c-ANCA-positive disease. Nine patients with Henoch-Schönlein purpura were studied as an ANCA-negative control group. Serum ceruloplasmin levels in p-ANCA-, c-ANCA-positive patients, and controls were 125.85+/-93.48 mg/dl, 59.79+/-17.60 mg/dl, and 64.34+/-18.77 mg/dl, respectively, and were significantly higher in patients with p-ANCA ( P<0.05). Ceruloplasmin levels were significantly decreased in remission ( P<0.05). Median MPO level in p-ANCA-positive patients was 15.2 (5-250) and was negative in all c-ANCA-positive patients. There was a significant positive correlation between MPO and ceruloplasmin levels ( r=0.70, P<0.05). Of 26 patients (53.8%) in the p-ANCA-positive group, 14 had renal involvement. The patients with renal disease had significantly higher ceruloplasmin levels than others (151.17+/-92.14 and 134.64+/-95.16 mg/dl respectively, P<0.05). In conclusion, the increase in ceruloplasmin levels during the acute phase suggests that this might be an activation criterion or a response to neutrophil-mediated tissue injury. Increased ceruloplasmin levels together with p-ANCA positivity may be predictive for renal involvement and a serious clinical course. The correlation between ceruloplasmin and MPO levels supports their association. Further studies are necessary to elucidate whether genetic and/or functional alterations in ceruloplasmin are effective in the pathogenesis of vasculitis.
抗髓过氧化物酶(MPO)抗体与抗中性粒细胞胞浆抗体(ANCA)相关血管炎的发生有关。中性粒细胞中蛋白酶 - 抗蛋白酶活性的失衡被认为与ANCA相关血管炎的发病机制有关。铜蓝蛋白是一种急性期蛋白,具有抗蛋白酶和抗氧化特性,并能抑制MPO活性。我们试图研究儿童血管炎患者血清铜蓝蛋白与ANCA之间的关联。本研究纳入了45例ANCA相关疾病患者。年龄范围为4至16岁。根据间接免疫荧光和/或ELISA特异性(MPO)将患者分为两组。26例患者为p - ANCA阳性,19例患者为c - ANCA阳性疾病。9例过敏性紫癜患者作为ANCA阴性对照组进行研究。p - ANCA阳性、c - ANCA阳性患者及对照组的血清铜蓝蛋白水平分别为125.85±93.48mg/dl、59.79±17.60mg/dl和64.34±18.77mg/dl,p - ANCA阳性患者的血清铜蓝蛋白水平显著更高(P<0.05)。缓解期铜蓝蛋白水平显著降低(P<0.05)。p - ANCA阳性患者的MPO水平中位数为15.2(5 - 250),所有c - ANCA阳性患者的MPO水平均为阴性。MPO与铜蓝蛋白水平之间存在显著正相关(r = 0.70,P<0.05)。在p - ANCA阳性组的26例患者(53.8%)中,14例有肾脏受累。肾病患者的铜蓝蛋白水平显著高于其他患者(分别为151.17±92.14和134.64±95.16mg/dl,P<0.05)。总之,急性期铜蓝蛋白水平升高表明这可能是一种激活标准或对中性粒细胞介导的组织损伤的反应。铜蓝蛋白水平升高与p - ANCA阳性可能预示肾脏受累及严重的临床病程。铜蓝蛋白与MPO水平之间的相关性支持了它们之间的关联。需要进一步研究以阐明铜蓝蛋白的基因和/或功能改变是否在血管炎的发病机制中起作用。